Delivery Order SPE2DB20D1100-SPE2DB25FC8E6

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,413.50 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS and has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a firm fixed price of $1,391.00 and a completion date of June 12, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,174,376 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The total ceiling value of the contract is $10,634.56, with a period of performance through May 8, 2025. The contract is not set-aside and was awarded on May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,583,518 units of NAYZILAM 5 MG nasal sprays. The $1,208.20 contract has a performance period through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds a $999,999,999.00 indefinite...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation, a $1,008.39 firm fixed price delivery order contract to supply 4564168540 units of the specialty pharmaceutical product NAYZILAM 5 MG NASAL SPRAYS. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract, valued at $12,453.44, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key pharmaceutical supplier supporting the Department of Defense's military treatment programs and medical facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. The contract has a ceiling value of $1,008.39 and runs through September 24, 2024. It is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, with a ceiling value of $2,147.48 and a completion date of May 27, 2025. The contract is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,133.94, is for the supply of 4,567,875,332 units of the medication NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NAYZILAM 5 MG nasal sprays. The $1,152.24 firm fixed-price contract has a completion date of November 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC8E6
    Delivery Order

This is a $1,391.00 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of June 11, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:44 PM